# A248 ETHANOL-INDUCED MUCOSAL IRRITATION DISRUPTS LOCAL AND SYSTEMIC PROTECTIVE EFFECTS OF NON-INVASIVE TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION (TAVNS)

**Authors:** F Hesampour, C N Bernstein, J Ghia

PMC · DOI: 10.1093/jcag/gwae059.248 · Journal of the Canadian Association of Gastroenterology · 2025-02-10

## TL;DR

This study shows that a small amount of ethanol-induced irritation can cancel the protective effects of a non-invasive nerve stimulation technique on gut and immune health in mice.

## Contribution

The study reveals that minor mucosal irritation disrupts the anti-inflammatory and anti-apoptotic benefits of taVNS in mice.

## Key findings

- taVNS increased anti-inflammatory markers in control mice but not in ethanol-treated mice.
- Ethanol-induced irritation prevented taVNS from reducing pro-apoptotic gene expression in the colon.
- Spleen responses to taVNS were also blocked by ethanol-induced mucosal irritation.

## Abstract

The integrity of the mucosal barrier is vital for gastrointestinal homeostasis. Previously, we demonstrated that non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) decreases inflammatory and pro-apoptotic markers while increasing anti-inflammatory markers in homeostatic conditions. However, its effectiveness in case of slight mucosal irritation remains unclear.

To assess whether slight mucosal irritation affects taVNS efficacy in modulating pro- and anti-inflammatory cytokines and apoptosis-related markers in the colon and spleen.

Male C57BL/6 mice were given a single intrarectal dose of 30% ethanol (ETOH group, 100 µl), while the control (CTRL) group received no ethanol. Preventive taVNS (10V, 20Hz & 500us, 10min/day) or no stimulation (clipping only) began one day before ethanol injection and continued for four days. Colonic and splenic levels of interleukin (IL)-10, tumor growth factor (TGF)-β, tumor necrosis factor (TNF)-α, pro-apoptotic markers Bcl-2-associated X protein (BAX), Bcl-2 homologous antagonist killer (BAK1), caspase8, and pro-survival BCL2 associated agonist of cell death (BAD) were measured using qRT-PCR and ELISA.

taVNS significantly increased IL-10 mRNA expression (p<0.0001) and both mRNA (p<0.015) and protein (p<0.0001) levels of TGF-β in CTRL conditions, with no changes in the ETOH group. Mice demonstrated unchanged IL-10 protein levels in the colon in the presence or absence of taVNS. However, in CTRL conditions, taVNS downregulated BAX (p<0.0001), BAK1(p<0.0001), and caspase8 (p<0.0002) mRNA expression significantly, with no effect in the ETOH group. Additionally, BAD (p<0.0001) mRNA expression increased significantly in CTRL conditions but remained unchanged in the ETOH group. In the spleen, taVNS decreased TNF-α (p<0.04) and increased TGF-β (p<0.0007) protein levels in CTRL conditions without impacting the ETOH group.

Our findings demonstrated that taVNS successfully regulated systemic and local cytokines and apoptosis-related markers in control mice. However, a slight irritation induced by ethanol abolished its effects, indicating that ethanol associated with a slight mucosa irritation can modify the taVNS outcome.

CIHR

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578], casp8 (caspase 8, apoptosis-related cysteine peptidase) [NCBI Gene 58022], BAD (BCL2 associated agonist of cell death) [NCBI Gene 572], IL10 (interleukin 10) [NCBI Gene 3586], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], TNF (tumor necrosis factor) [NCBI Gene 7124]
- **Chemicals:** ethanol (PubChem CID 702)

---
Source: https://tomesphere.com/paper/PMC11807712